Table 1.
N | Duration (months) | Baseline HbA1c (%) | Placebo-subtracted change in HbA1c (%) | P | |
---|---|---|---|---|---|
Monotherapy |
159 |
6 |
8.7 |
−0.56 |
<0.02 |
Add-on to SU |
494 |
6 |
9.4 |
−0.55 |
<0.0001 |
Add-on to various OHAs | 3,095 | 12 | 8.3 | −0.6 to −0.9 | <0.01–0.001 |
SU, sulfonylurea.